AEG — Aegon Ltd.

AEG Earnings Call Summary (Q2 2025)

1. Key Financial Results and Metrics

• Operating Result: EUR 845 million, a 19% increase year-over-year, primarily due to profitable business growth and improved claims experience in the U.S. and U.K.
• Operating Capital Generation (OCG): EUR 576 million, down 2% from the previous year, impacted by increased new business strain.
• Free Cash Flow: EUR 442 million, up from EUR 373 million in the prior year.
• Cash Capital at Holding: Over EUR 2 billion, enabling a EUR 200 million increase in the share buyback program to a total of EUR 400 million for H2 2025.
• Interim Dividend: Increased by EUR 0.03 to EUR 0.19 per common share.
• Group Solvency Ratio: Decreased by 5 percentage points to 183%, influenced by the share buyback and interim dividend reservations.

2. Strategic Updates and Business Highlights

• Transformation Strategy: Aegon is focused on growing and transforming its business, with a significant emphasis on the U.S. market, which now represents 70% of operations.
• Head Office Relocation Review: Aegon is considering relocating its head office to the U.S. to align with its primary market, simplify corporate structure, and enhance operational efficiency.
• Commercial Performance: Strong growth in new life sales, particularly in the U.S. Individual Life business, with a 13% increase attributed to higher agent productivity and successful product launches.
• U.S. Variable Annuity Portfolio: Extended hedging to cover part of the base fee exposure, reducing economic equity market exposure.

3. Forward Guidance and Outlook

• U.S. Operating Results Guidance: Increased by EUR 50 million to a range of EUR 700 million to EUR 800 million for the year.
• Group Operating Results Guidance: Remains unchanged at EUR 750 million to EUR 850 million.
• OCG Expectation: Anticipated to be around EUR 1.2 billion for the full year 2025.

4. Bad News, Challenges, or Points of Concern

• New Business Strain: Increased, particularly in U.S. strategic assets, which may pressure future OCG.
• Exchange Rate Impact: Valuation equity per share decreased by 5% due to unfavorable currency movements.
• Claims Experience: Although overall mortality was slightly positive, there were concerns about the impact of unfavorable claims experience on profitability.
• Regulatory Challenges: Transitioning to U.S. GAAP is complex and expected to take 2-3 years, posing operational challenges.

5. Notable Q&A Insights

• Variable Annuity Hedging: Management indicated that the decision to hedge 25% of variable annuity fees was a prudent step to stabilize capital generation.
• Redomiciliation Rationale: The move is seen as logical given the U.S. market's significance to Aegon's business, with no regulatory pressure cited for the decision.
• M&A Strategy: Aegon remains disciplined in pursuing acquisitions, focusing on opportunities that align with its strategic goals.
• Mortality Assumptions: Management expressed confidence in their mortality assumptions, noting that recent experiences were in line with expectations.

This summary encapsulates Aegon's financial performance, strategic initiatives, and outlook while highlighting areas of concern and insights from the Q&A session.